ILLUMINA INC
ILMN · NASDAQ
Updated at 2026-10-14 10:21:07
- Today's High
- $276.85
- Today’s Low
- $267.27
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $277.60
- Previous Close
- $276.67
- Volume
- 1.64M
- Market Cap
- $41.77B
- P/E Ratio
- 50.31X
- EPS
- $5.38
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- DIAGNOSTICS & RESEARCH
- Headquarters
- 5200 ILLUMINA WAY, SAN DIEGO, CA, UNITED STATES, 92122
- Country
- US
- Listing Date
- 2000-06-28
- Fiscal Year End
- December
- Shares Outstanding
- 151.3M
- CIK
- 0001110803
- Website
- www.illumina.com
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$1.15B
2026-03-31
$1.09B
2025-12-31
$1.16B
2025-09-30
$1.08B
Operating Expenses
2026-06-30
$525M
2026-03-31
$512M
2025-12-31
$521M
2025-09-30
$501M
Net Income
2026-06-30
$207M
2026-03-31
$134M
2025-12-31
$334M
2025-09-30
$150M
Net Profit Margin
2026-06-30
17.86%
2026-03-31
12.28%
2025-12-31
28.79%
2025-09-30
13.85%
Earnings Per Share
2026-06-30
$1.31
2026-03-31
$1.15
2025-12-31
$1.35
2025-09-30
$1.34
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$330M
2026-03-31
$250M
2025-12-31
$471M
2025-09-30
$312M
Effective Tax Rate
2026-06-30
20.38%
2026-03-31
14.64%
2025-12-31
11.64%
2025-09-30
31.81%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.15B | $1.09B | $1.16B | $1.08B |
| Operating Expenses | $525M | $512M | $521M | $501M |
| Net Income | $207M | $134M | $334M | $150M |
| Net Profit Margin | 17.86% | 12.28% | 28.79% | 13.85% |
| Earnings Per Share | $1.31 | $1.15 | $1.35 | $1.34 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $330M | $250M | $471M | $312M |
| Effective Tax Rate | 20.38% | 14.64% | 11.64% | 31.81% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.